Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Stemtech Corp

CIK: 15118202 Annual ReportsLatest: 2025-06-30

10-K / June 30, 2025

Revenue:$5,053,690
Income:-$3,772,701

10-K / July 10, 2024

Revenue:$4,921,531
Income:-$5,430,245

10-K / June 30, 2025

Company Summary: Stemtech Corporation

Business Overview

  • Type of Business:
    Global network marketing company focused on developing science-based wellness products, particularly related to stem cell science.

  • Core Product Focus:
    Supports wellness by helping the body maintain healthy stem cell physiology through stem cell enhancers. These products aim to:

    • Release the body’s own stem cells
    • Promote circulation of stem cells in the blood
    • Facilitate migration of stem cells into tissues for renewal and repair
  • Product Attributes:

    • Products are all-natural, plant-based botanicals.
    • Do not contain actual stem cells but support their natural function.
    • Marketed as Stem Cell Nutrition™, with products like the RCM System, stemrelease3™, StemFlo®, MigraStem®, OraStem®, and skincare lines like Cellect One® Night Cream and Shield HOCL.
  • Market & Distribution:

    • Marketed internationally via subsidiaries and independent distributors.
    • Primary channels include an independent distributor (IBP) network and direct-to-consumer (DTC) retail model.
    • Plans to expand with new products like StemPets™ for pets, targeting the $303 billion global pet industry.

Financial and Operational Details

  • Employees & Customers:
    Specific number of employees and customers not provided.

  • Revenue & Income:

    • 2024 Revenue: Approximately $5,053,690
    • 2023 Revenue: Approximately $4,921,531
    • 2024 Net Loss: $3,772,701 (improved from $5,431,979 in 2023)
    • 2023 Net Loss: $5,431,979
  • Additional Business Information:

    • The company emphasizes expanding its independent distributor network, projecting the addition of 30,000 new IBPs over 12-24 months.
    • Operates on a network marketing model combining international subsidiaries, independent distributors, and direct-to-consumer sales.
    • The company has been recognized four times in the Inc 5000 list of fastest-growing companies.

Regulatory & Corporate Details

  • Legal & Regulatory:
    • Noted ongoing legal proceedings related to unpaid salary claims.
    • The company is a Nevada-incorporated entity, with a fiscal year-end changed to December 31, as of November 2021.
    • Market trading symbol: STEK (OTCQB market).
    • Total shares outstanding as of June 30, 2025: 142,443,444 shares.

Strategic Focus

  • Reinforce product offerings and expand the distributor network.
  • Introduce new products to increase market penetration, including pet and skincare lines.
  • Aspire to grow revenues and move toward profitability while managing substantial net losses and a significant accumulated deficit.
  • Focus on global expansion and leveraging a flexible, network-driven distribution strategy.